Nov. 2, 2021 – “Any adverse downstream consequences flowing from medically appropriate prescriptions cannot constitute an actionable public nuisance,” the ruling said.
Los Angeles, Orange and Santa Clara counties and the city of Oakland argued that the pharmaceutical companies misled both doctors and patients by downplaying the risks of addictions, overdoses, deaths and other health complications while overstating the benefits for long-term health conditions.
The plaintiffs said they were disappointed by the ruling but planned to appeal to “ensure no opioid manufacturer can engage in reckless corporate practices that compromise public health in the state for their own profit.”
The lawsuit names Johnson & Johnson, along with AbbVie Inc’s Allergan subsidiary, Endo International, Teva Pharmaceutical Industries and others.
The companies had argued in court filings “that opioid medications are an appropriate treatment for many chronic-pain patients” and that much of their marketing mimicked approved warnings by the U.S. Food and Drug Administration.
Historically, the local jurisdictions say, the powerful drugs had been used only immediately after surgeries or for other acute, short-term pain, or for cancer or palliative care.
SHE’D NEVER DRAG HIM DOWN – April 10, 2024 - Ariana Grande is a…
WHAT GOES AROUND... – April 9, 2024 - In a cover profile of RDJ…
VIDEO – ONE MARRIAGE AT A TIME – April 10, 2024 - “Alcohol made…
HAS HE MADE HIS AMENDS? – April, 2024 - “Manson hasn’t been out on…
VIDEO – IN ALL OUR ENDEAVORS – April 9, 2024 - Within the structure…